Greatland Resources Ltd (AIM:GGP, OTC:GRLGF, FRA:G8G, ASX:GGP) has announced a change to its senior leadership team, with chief operating officer Simon Tyrrell resigning from his role.
The company said Tyrrell has stepped down as COO but will remain available until June 30, 2026, to assist with the transition. A formal process to appoint a permanent replacement is now under way.
The S&P/ASX Small Ordinaries (XSO) closed at 3,641.10, down 13.90 points (-0.38%) in the previous session and down 97.60 points (-2.61%) over the past five days.
In Perth, the RIU Explorers Conference is underway and due to wrap up tomorrow. With a heavy presenting schedule across the resources sector, company news flow is a little slower than usual, but several updates are landing throughout the day.
Immunic Inc (NASDAQ:IMUX) said on Tuesday it has closed a previously disclosed private placement financing, raising $200 million upfront with the potential to secure up to an additional $200 million.
The New York-based biotechnology company issued just over 229 million pre-funded warrants at a price of $0.873 each, generating gross upfront proceeds of $200 million.
Analysts from Lucid Capital, H.C. Wainwright, and B. Riley Securities have all repeated ‘Buy’ ratings on OKYO Pharma Ltd (NASDAQ:OKYO), highlighting the company’s promising urcosimod program and its potential to address an unmet need in neuropathic corneal pain (NCP).
The positive sentiment follows a successful Type C meeting with the US Food and Drug Administration (FDA), which confirmed the company’s proposed trial design, primary endpoint, and overall regulatory approach.
Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID) announced that it has entered strategic discussions with Nigeria’s National Information Technology Development Agency (NITDA) aimed at strengthening the country’s digital trust framework and supporting the growth of its digital economy.
The provider of AI-powered identity and security solutions said the talks focus on integrating privacy-first biometric technologies into Nigeria’s expanding digital infrastructure.
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE, FRA:YO0, BVC:HIVECO) has reported its financial results for the third quarter ended December 31, 2025, posting record revenue and expansion of its digital infrastructure.
The company reported quarterly revenue of $93.1 million, up 219% from $29.2 million in the same period last year and 7% higher than the prior quarter.
OptiBiotix Health PLC (AIM:OPTI, OTCQB:OPTBF) shares rose 10% to 6.42p on Tuesday after the life sciences group said it had no current intention to sell its 5.64% stake in SkinBioTherapeutics following market uncertainty caused by recent statements from the skincare company.
OptiBiotix also said it had not sold any shares in ProBiotix Health and had no current plans to do so.
Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF, FRA:TMU), in its full-year results statement, highlighted momentum in Zambia, where it works alongside First Quantum Minerals and KoBold Metals.
The company said its data-sharing and technical cooperation agreement with First Quantum “has led directly” to a new copper-silver discovery at Mushima North, now described as its lead project.
Empire Metals Ltd has kicked off what it calls its largest drilling campaign to date at the Pitfield titanium project in Western Australia, a fully funded programme designed to expand its resource base and upgrade confidence at its Thomas and Cosgrove deposits.
The AIM-quoted explorer plans 754 holes for around 41,250 metres of drilling, split between 683 air-core holes (34,150m) and 71 reverse-circulation holes (7,100m). The company expects to run three air-core rigs and two RC rigs, with drilling forecast to finish by mid-April.
In a significant patent skirmish for the Australian biotech and pharmaceutical sector, AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured a Federal Court ruling that blocks local generics maker Pharmacor Pty Ltd from selling its cheaper versions of the diabetes drug dapagliflozin — at least until a full trial can be heard. The decision is a win for originator drugmakers in a legal landscape where innovators and generics are increasingly clashing over market access and patent rights.
Justice Kylie Downes of the Federal Court on Monday granted an interlocutory injunction restraining Pharmacor from selling, supplying or otherwise disposing of multiple dapagliflozin products in Australia before the expiry of AstraZeneca’s patent, or further order of the Court. The order also requires Pharmacor to withdraw or adjust its pending Pharmaceutical Benefits Scheme (PBS) listing applications for its generic products.
Resolution Minerals Ltd (ASX:RML, OTC:RLMLF, FRA:NC3) has reported further broad gold intersections and a significant tungsten hit from final assays of its 2025 drilling campaign at the Golden Gate Fault Zone within the 100%-owned Horse Heaven Gold–Antimony–Tungsten–Silver Project in Idaho, USA.
Anson Resources Ltd (ASX:ASN, OTCQB:ANSNF) will start a uranium and vanadium drilling program in early March 2026 at its Yellow Cat U-V Project in Utah, targeting a 2,500-metre extension of mineralisation along strike of the historical resource.
The program will focus on the eastern block of the project, where mineralisation is shallow or outcropping and positioned above the water table, supporting planned drill depths of 12 metres to 40 metres. A drilling contractor has been selected, with mobilisation scheduled for early March.
Sovereign Metals Ltd (ASX:SVM, OTCQX:SVMLF, AIM:SVML, FRA:SVM) has signed a non-binding memorandum of understanding (MOU) with Traxys North America LLC to market graphite from its Kasiya Rutile-Graphite Project in Malawi — linking the project to a trading house recently appointed to procure critical minerals for the United States’ new strategic reserve.
Traxys is one of only three trading houses selected to procure materials under Project Vault, the US$12 billion public-private initiative launched this month to establish a US Strategic Critical Minerals Reserve. The move places Kasiya’s planned graphite production in proximity to a government-backed stockpiling program aimed at reducing reliance on Chinese-dominated supply chains.